DBV Technologies S.A. (EPA:DBV)
1.942
+0.154 (8.61%)
May 12, 2025, 5:35 PM CET
DBV Technologies Employees
As of December 31, 2024, DBV Technologies had 110 total employees, including 109 full-time and 1 part-time employees. The number of employees increased by 5 or 4.76% compared to the previous year.
Employees
110
Change (1Y)
5
Growth (1Y)
4.76%
Revenue / Employee
€30,523
Profits / Employee
€991,989
Market Cap
265.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sanofi | 82,878 |
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 6,365 |
emeis Société anonyme | 83,494 |
DBV Technologies News
- 7 days ago - DBV Technologies to Participate in the Citizens JMP Life Sciences Conference - GlobeNewsWire
- 12 days ago - DBV Technologies Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document - GlobeNewsWire
- 6 weeks ago - Why DBV Technologies (DBVT) Stock Is Skyrocketing - Benzinga
- 6 weeks ago - DBV Technologies ADRs Rise After Up to $306.9M in New Financing - Market Watch
- 6 weeks ago - DBV Technologies announces up to $307M financing to advance Viaskin Peanut program - Seeking Alpha
- 6 weeks ago - DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved - GlobeNewsWire
- 7 weeks ago - DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results - GlobeNewsWire